Form 4: Guardant Health Director Myrtle S. Potter Reports Stock Transactions
SEC Form 4 Filing
Director Myrtle S. Potter reports the vesting and subsequent ownership of Guardant Health common stock.
Summary
- On October 15, 2024, Director Myrtle S. Potter reported a transaction involving Guardant Health, Inc. common stock.
- The transaction involved the vesting of restricted stock units and the subsequent ownership of 69 shares of common stock.
- Following the reported transaction, Ms. Potter directly owns 13,585 shares of Guardant Health common stock and 821 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral report of stock transactions by a company director. It doesn't inherently indicate positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it represents a small change in the director's holdings.
Key Dates
| Date | Description |
|---|---|
| October 15, 2022 | Initial vesting date for 25% of the restricted stock units. |
| October 15, 2024 | Date of the reported transaction involving the vesting of restricted stock units and ownership of common stock. |
| October 16, 2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.